- Halo Collective's (OTCQB:HCANF) wholly-owned subsidiary Bophelo Bioscience & Wellness completed its first sale of cannabis flower to a licensed cannabis producer and exporter based in Lesotho, Africa.
- The license-to-license market in Africa is estimated to be $7.1B by 2023 and Bophelo is uniquely positioned to capitalize by cultivating high quality flower at affordable prices for African patients.
- "As Bophelo begin sales in Africa and soon in Europe, Halo believe that our sales from Bophelo could exceed our sales in California within months and Oregon within a year. This initial sale, with potential revenue of over six times Bophelo's estimated cultivation costs, leads Halo to believe that Bophelo can become profitable in 2021," founder & Head of International Operations Andreas Met commented.